NextVivo
PrivateLast Round
Seed
Dec 9, 2021
Total Funding Raised
$7.9M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
NextVivo is a biotechnology company that develops an immune organoid technology platform to create three-dimensional, immune-competent models of human tissues for drug discovery and therapeutic development.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NextVivo Comparables
Compare NextVivo with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Parallel Bio | 87% | |
| Vivodyne | 86% | |
| Xilis | 85% | |
NextVivo Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Dec 9, 2021 |
NextVivo Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Khosla Ventures | Seed |
| Alexandria Venture Investments | Seed |
| Wilson Sonsini Goodrich & Rosati | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors grew 230% MoM, reaching 479.
- May 4, 2025
Monthly visitors increased 4679% from 14 to 669.
NextVivo Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about NextVivo's valuation, stock price, and market status.